Australia's largest stock trading and investment forum Australia's #1 stock forum

DLM

Click for more information

0.00%

3.2¢ dominion minerals limited

Sad that my concerns were valid. I don't see much value left in...

First 28 Last

Share
Profile

Follow
CaptainBarnacles

11,118 Posts.

683

14/11/18

09:23

Post #: 36495250
Share

Originally posted by CaptainBarnacles: ↑

Trying to get some thoughts on this, as I do like what FTT is trying to acheive. Have been considering buying the dip after the crap raise.

In the Data quality from the pres, there are very few trial patients in the 51 to 100 pain score end. There are actually fewer than you would expect from the placebo cohort alone using Venus as a standard of care baseline IMO, let alone with 2/3rds actives included. So to me it looks like the placebo standard of care is producing far better outcomes that Venus.

Isn't there a risk that due to either a better standard of care, or due to sicker patients who have had no medical care at all (or self care?), and a re easier to improve (as the presentation says that there are very few drop outs - could it be these patients have few options), that we may be seeing a placebo group that is significantly outperforming expectations?

I've not done much research tbh - so not recommending anybody panic - lol - just asking!

Expand

Sad that my concerns were valid. I don't see much value left in this business. I would take what I could get if I held. I was watching this stock for today's news - as I thought it would be a massive upside surprise if it succeeded. My commiserations to holders.

FTT Price at posting: 7.3¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

Emerald & Azure score Digger & Dealer awards

Bitcoin: Current State of Play & Where to Next | Swyftx

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

TNC

True North increases silver metal at QLD's Vero deposit by 20%

Revolutionary inverter technology leads the clean energy charge

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

There are more pages in this discussion • 1 more message in this thread...

First 28 Last

Add DLM (ASX) to my watchlist